Preventing Mitochondrial Oxidative Stress in Diabetes and Obesity
The summary for the Preventing Mitochondrial Oxidative Stress in Diabetes and Obesity grant is detailed below.
This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants.
Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact.
If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Preventing Mitochondrial Oxidative Stress in Diabetes and Obesity: - Hyperglycemia is a significant causative factor for the complications of diabetes mellitus, which results in significant morbidity and mortality for millions of Americans. Recent advances on the cellular effects of hyperglycemia places the overproduction of reactive oxygen species (ROS) by the mitochondrial electron transport chain as a strong candidate for the core abnormality that leads to other biochemical and cellular defects and the resulting tissue injury. The purpose of this RFA is to encourage the translation of these recent advances into therapies that can interrupt the increase in mitochondrial ROS and prevent their role in diabetic complications. - R01 and R21 applications from qualified principal investigators are invited for basic or clinical studies for discovering and characterizing molecular targets, agents and assays related to the accumulation of mitochondrial ROS secondary to hyperglycemia. - The participating institutes plan on contributing $2.5 million to fund 5-10 new awards with project periods of 2-4 years. - Non-profit or for-profit organizations are eligible, including public or private institutions and domestic and foreign institutions. - Applicants may submit more than one application, providing there is no scientific or budgetary overlap. - The PHS 398 application can be obtained from http://grants.nih.gov/grants/funding/phs398/phs398.html
| Federal Grant Title: | Preventing Mitochondrial Oxidative Stress in Diabetes and Obesity |
| Federal Agency Name: | National Institutes of Health |
| Grant Categories: | Health Education |
| Type of Opportunity: | Discretionary |
| Funding Opportunity Number: | RFA-DK-05-001 |
| Type of Funding: | Grant |
| CFDA Numbers: | 93.39393.396 |
| CFDA Descriptions: | Cancer Cause and Prevention Research 93.396 Cancer Biology Research |
| Current Application Deadline: | No deadline provided |
| Original Application Deadline: | Feb 24, 2005 |
| Posted Date: | Nov 30, 2004 |
| Creation Date: | Nov 30, 2004 |
| Archive Date: | Mar 26, 2005 |
| Total Program Funding: | $2,500,000 |
| Maximum Federal Grant Award: | |
| Minimum Federal Grant Award: | |
| Expected Number of Awards: | 5 |
| Cost Sharing or Matching: | 93.847 -- Diabetes, Endocrinology and Metabolism Research |
- Applicants Eligible for this Grant
- Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education For profit organizations other than small businesses Small businesses Public and State controlled institutions of higher education Private institutions of higher education State governments County governments City or township governments Special district governments Independent school districts Native American tribal governments (Federally recognized) Public housing authorities/Indian housing authorities Native American tribal organizations (other than Federally recognized tribal governments) Others (see text field entitled "Additional Information on Eligibility" for clarification)
- Additional Information on Eligibility
- Eligible agencies of the Federal Government are eligible to apply. Foreign institutions are eligible to apply. Foreign institutions/organizations considering applying to this RFA must demonstrate an ability to conduct the proposed study in the designated setting(s), as well as an ability to meet government clearance requirements.
- Link to Full Grant Announcement
- Information not provided
- Grant Announcement Contact
- If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [email protected] NIH OER Webmaster